No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SIBN240719C12500
- 0.60
- +0.10+20.00%
15min DelayClose Jul 5 15:59 ET
0.60High0.60Low
0.60Open0.50Pre Close2 Volume2.50K Open Interest12.50Strike Price120.00Turnover68.42%IV0.85%PremiumJul 19, 2024Expiry Date0.49Intrinsic Value100Multiplier13DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type0.6460Delta0.2196Gamma13.67Leverage Ratio-0.0253Theta0.0027Rho8.83Eff Leverage0.0092Vega
Intraday
- 5D
- Daily
News
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company
6 of the Top 10 Medical Device Manufacturers Rely On AcuityMD's Commercial Intelligence Platform to Modernize Operations, Drive Revenue
AcuityMD now supports more than 200 MedTech companies, including leaders BD and SI-BONEBOSTON--(BUSINESS WIRE)--AcuityMD today announced its commercial intelligence platform for medical technology (Me
Osteotec Announces Exclusive UK and Ireland Distribution Agreement With SI-BONE
NEWBURY, England, May 16, 2024 /PRNewswire/ -- Osteotec, the market-leading manufacturer and distributor of medical devices, is pleased to announce a new partnership with SI-BONE to exclusively distr
Osteotec Announces Lisa Watts as National Sales Manager of New Spine Division
NEWBURY, England, May 15, 2024 /PRNewswire/ -- Osteotec, the market-leading manufacturer and distributor of medical devices, today announced it has strengthened its leadership team with the appointme
SI-BONE, Inc.'s (NASDAQ:SIBN) Price In Tune With Revenues
With a price-to-sales (or "P/S") ratio of 4.5x SI-BONE, Inc. (NASDAQ:SIBN) may be sending bearish signals at the moment, given that almost half of all Medical Equipment companies in the United States
Si-Bone Launches IFuse Bedrock Granite Implant System
Comments
The recent insider sale of SI-BONE shares and the absence of insider purchases over the past year might worry investors. The low level of insider ownership and recent selling activity could indicate a misalignment between insiders and other shareholders.
Have Insiders Sold SI-BONE Shares Recently?SI-BONE's high P/S ratio is justified by its superior revenue growth and future prospects. Shareholders are confident in the company's future revenues, keeping the share price buoyant.
Multiple insider stock sales over the past year, including a notable sale at the current price, suggests reduced confidence in the firm's equity. The lack of insider purchases enhances these doubts about prospective share performance. Even with insider ownership, the ongoing sell-off hints at a careful approach to buying the company's stock.
The company's future could potentially bright despite underperformance, due to revenue growth. However, past unprofitability may have affected investors' sentiment. Note the 3 warning signs for SI-BONE as possible risks.
Read more